What Clinical Shifts Are Shaping the Cholesterol Drug Market?

hat ein neuen Blog hinzugefügt Health

2026-07-29 07:51:50 -

The cholesterol drug landscape remains a cornerstone of cardiovascular preventive medicine, aimed at managing dyslipidemia, lowering low-density lipoprotein cholesterol (LDL-C), and reducing atherothrombotic event risks. While HMG-CoA reductase inhibitors (statins) remain first-line foundational therapy, many high-risk patients require additional lipid-lowering agents to reach target European...

0 Kommentare 0 Geteilt 452 Ansichten 0 Bewertungen